Molbio Diagnostics Limited

₹1,360As of Sun 8 Nov 2026, 12:00 UTC
NSE:MOLBIOHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Medical Devices
Beta (5Y) —
PE TTM 99.67
TSR TTM —
Mkt cap ₹156.7B
ROIC 11.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,645
20.93%
(63.28%)
Hold 11|10|1|6|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
12.50
12.39
12.82
14.10
7.60%
9.08%
11.01%
23.97%
Revenue₹B
7.589
7.958
8.245
8.036
10.69%
10.28%
11.26%
4.84%
Peers (US$1.653B)
Cap (US$)
PE
546.9M
75.34x
422.8M
—
170.5M
57.51x
Capital
TTM
5Y
10Y
Leveragex
0.169
0.490
0.363
EBIT/Intx
2.000
0.241
0.229
Own earn%
(13.93)
(118.99)
(119.09)
Sh yield%
50.15
13.87
18.80
Owners
Insiders/Inst%
3.03
23.80
Short interest%
4.45
SBC / revenue%
3.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
15–29
$1 testx
0.0
Incr. ROIC%
15